TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | 7 | 13 | 39 | 4 | 14 | 0 | 15 |
| P | %wins | 100 | 100 | 100 | 100 | 100 | 100 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/17 16:11 | 7/31/17 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bisgaier Charles Phd | MI | DOT | Chief Sc | M.d | 6 | 1.34 | 0 | 4 | 0 | 1,350 | D | ||||||||||||||
8/12/16 12:47 | 8/10/16 | GEMP | Gemphire Therapeutics Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bisgaier Charles Phd | MI | DOT | Chair,Ch | P.d | 518 | 10.00 | 0 | 52 | 4 | 1,346 | M | 0 | 7 | 13 | 39 | 4 | 14 | ||||||||
7/17/07 13:21 | 7/16/07 | PP | Pipex Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Bisgaier Charles Phd | MI | DO | P | P.d | 46 | 4.64 | 0 | 10 | 3 | 332 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |